Erectile dysfunction decisions — 2025

The Board granted service connection for erectile dysfunction and denied increased ratings for left and right ankle disabilities. The issue of tinnitus was remanded for further development.

The Board remands the claims for service connection for diabetes, hypertension, and erectile dysfunction to allow for additional development, including verification of in-service toxic exposures and obtaining a medical opinion under the PACT Act.

The Board remands the claims for service connection for back condition, erectile dysfunction, sleep apnea (secondary to psychiatric disorder), and migraines/headaches due to a need for additional evidence.

The Board granted earlier effective dates for service connection and special monthly compensation, as well as a 40 percent rating for degenerative arthritis of the lumbar spine.

The Board remands the claims for service connection for prostate cancer, diabetes mellitus Type II, and erectile dysfunction due to pre-decisional duty to assist errors.

The appeal regarding service connection for erectile dysfunction as secondary to prostate cancer with herbicide exposure was dismissed as the claim was fully resolved in favor of the veteran.

The Board granted an earlier effective date of March 3, 2006 for the award of service connection for erectile dysfunction and granted increased ratings for neurogenic bowel and bladder impairments in certain periods.

The Board granted an effective date of December 28, 2020, for a 70 percent disability rating for PTSD and service connection for erectile dysfunction, SMC for loss of a creative organ, and pseudofolliculitis barbae with an effective date of December 14, 2021.

The Board denied the appellant's claim for direct payment of attorney fees from past due benefits awarded in an August 2023 rating decision granting service connection for Parkinson's disease and related symptoms.

The Veteran's erectile dysfunction results in loss of use of a creative organ, and he is granted special monthly compensation based on this condition.

The Board denied an initial rating in excess of 20 percent for Type II diabetes mellitus and remanded the issues of service connection for erectile dysfunction, a recurrent urinary disability to include urinary frequency, a recurrent liver disability to include non alcoholic fatty liver disease, and a recurrent gastrointestinal disability to include diverticulitis.

The Board remands the claims for an earlier effective date for service connection of prostate cancer and Non-Hodgkin Lymphoma due to in-service exposure to radiation, ionizing radiation, and environmental hazards on a direct basis.

The Board denied service connection for prostate cancer and remanded the claims for hypertension, ED, and SMC based on loss of use.

The Board granted service connection for neuropathy of the bilateral upper and lower extremities, hypertension, aortic aneurysm and aortic regurgitation as secondary to hypertension, and prostate cancer with associated erectile dysfunction. The claims for diabetes mellitus, type II, obstructive sleep apnea, an immune disorder, and a liver disability were remanded.

The Board denied an initial compensable rating for service-connected acne and remanded claims for service connection for erectile dysfunction, headaches and migraines, a right knee disability, and a left knee disability.

The Board remands the claims for service connection for ED, multiple joint rheumatoid arthritis, neck disability with cervical radiculopathy and degenerative arthritis, and back disability with bilateral lumbar radiculopathy and degenerative arthritis to obtain additional medical opinions that comply with previous remand directives.

The Board granted service connection for prostate cancer, diabetes mellitus with hypoglycemia, erectile dysfunction secondary to prostate cancer, and urinary incontinence secondary to prostate cancer. The claims for a bilateral eye disability, bilateral foot disability, joint pain (also claimed as arthritis), respiratory disorder, lung disability, chronic gastritis, and liver disability were remanded.

The Board granted service connection for testicular cancer and ED, both due to in-service exposure to jet fuel.

The Board remands the claims for service connection for erectile dysfunction and prostate cancer, status-post prostatectomy, to obtain additional medical evidence regarding their etiology, particularly in relation to the Veteran's confirmed exposure to contaminated water at Camp Lejeune.

The Board dismissed the claim for entitlement to TDIU since August 11, 2022, as moot due to a combined evaluation of 100 percent. The remaining issues are remanded for further development.